Ambulatory Surgery Center Market Size and Share

Ambulatory Surgery Center Market Summary
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Ambulatory Surgery Center Market Analysis by Mordor Intelligence

The Ambulatory Surgery Center Market size is estimated at USD 83.88 billion in 2025, and is expected to reach USD 110.15 billion by 2030, at a CAGR of 5.6% during the forecast period (2025-2030).

Rising pay-for-value models, payer pressure to lower procedure prices, and technological gains that enable higher-acuity cases outside hospital walls are accelerating facility build-outs. Orthopedics, ophthalmology, and pain management continue to anchor procedure volumes, yet cardiovascular and spine cases are expanding fastest because new CPT codes now qualify for ambulatory reimbursement. Operators that couple specialty diversification with automation tools are widening margins even as reimbursement headwinds persist. A competitive real-estate scramble, fueled by private-equity roll-ups, signals longer-term consolidation but near-term white-space remains in secondary cities and newly deregulated states.

Key Report Takeaways

  • By center type, single-specialty facilities controlled 62.32% of the ambulatory surgical centers market in 2024; multi-specialty centers are projected to expand at an 8.52% CAGR through 2030. 
  • By modality, freestanding centers accounted for 66.74% of the ambulatory surgical centers market size in 2024, and hospital-based sites are expected to post a 9.23% CAGR over 2025-2030. 
  • By ownership, physician-owned centers captured a 60.11% share of the ambulatory surgical centers market size in 2024, yet corporate-backed sites are advancing at a 10.12% CAGR. 
  • By services, surgical services held 77.23% of the ambulatory surgical centers market share in 2024, while cardiovascular procedures are forecast to rise at a 8.74% CAGR to 2030. 
  • By specialty, orthopedics held 30.22% of the ambulatory surgical centers market share in 2024, while cardiovascular procedures are forecast to rise at a 9.65% CAGR to 2030. 
  • By geography, North America led with 36.44% of the ambulatory surgical centers market share in 2024, while Asia is projected to log the fastest 10.37% CAGR through 2030.

Segment Analysis

By Center Type: Specialised Focus Remains Dominant While Diversification Gains Speed

Single-specialty centers generated 62.32% of 2024 revenue, underpinned by clinically efficient musculoskeletal, ophthalmic, and pain-management service lines. The operators of single-specialty sites reported average same-room turnover times under 14 minutes, a key factor in physician loyalty. Focused staffing models, equipment reuse, and aligned implant formularies have historically driven EBITDA margins into the mid-30% range.

Multi-specialty centers, while smaller today, are forecast to outgrow single-discipline peers at 8.52% annually through 2030. Diversified case mixes cushion reimbursement volatility and boost scheduling density across the week. Larger systems are layering endoscopy, ENT, and women’s health into existing orthopedic hubs, raising yield on fixed costs. This pivot is expected to push the multi-specialty slice of the ambulatory surgical centers market share several points higher over the next five years.

Market Share by Center Type
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Note: Segment shares of all individual segments available upon report purchase

Get Detailed Market Forecasts at the Most Granular Levels
Download PDF

By Modality: Freestanding Footprint Leads but Hospital-Based Growth Accelerates

Freestanding facilities held 66.74% of 2024 revenue. Their independence from hospital campuses allows flexible site selection near high-income suburbs and employer clusters, a distinct access advantage. Many also operate extended hours, capturing after-work cases that hospitals struggle to schedule.

Hospital-based ASCs represented 33.26% of revenue but are set to grow at a 9.23% CAGR. Health systems are converting underused procedural suites into compliant ambulatory sites to defend referral bases and secure downstream imaging and inpatient volumes. Early evidence suggests that alignment with hospital electronic health records shortens referral cycles, driving incremental growth. This shift should steadily lift the hospital-affiliated slice of the ambulatory surgical centers market size, especially for spine and structural heart programs that demand costly imaging infrastructure.

By Ownership: Physician Control Continues But Corporate Consolidation Intensifies

Physician owners commanded 60.11% of revenue in 2024, a testament to surgeon preference for clinical autonomy. Average distributions per partner remained attractive even after the 2.9% Medicare rate adjustment, keeping many single-site ventures independent. Yet corporate and private-equity platforms, benefiting from 7× EBITDA buyout leverage, are expanding at a 10.12% CAGR. Scale unlocks payer-contract clout, supply-chain rebates, and shared revenue-cycle services. Consequently, the corporate slice of the ambulatory surgical centers market share is likely to climb despite entrenched physician ownership.

Joint-venture structures offer a middle path, mixing surgeon governance with hospital capital. Tenet Healthcare’s USPI portfolio grew to 438 centers by 2021 and targets 575-600 by 2025, with management projecting ASC contributions to about half of adjusted EBITDA. Similar deals are rising in cardiovascular and gastroenterology niches where device costs are high.

By Services: Surgical Core Dominates While Diagnostics Gather Momentum

Surgical procedures produced 77.23% of 2024 revenue, reflecting that orthopedic joint replacement, cataract extraction, and pain injections remain top volume drivers. The ambulatory surgical centers market size for surgery is forecast to rise steadily, buoyed by expanding CPT approvals.

Diagnostic imaging and ancillary testing, comprising 22.77% of revenue, are poised for 8.74% annual growth. Centers adding on-site MRI or CT gain scheduling control and retain downstream income. CMS telehealth parity and caregiver-training codes, effective 2025, further support non-procedural revenue streams, strengthening diversification strategies.

Market Share by Services
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Note: Segment shares of all individual segments available upon report purchase

Get Detailed Market Forecasts at the Most Granular Levels
Download PDF

By Specialty: Orthopedics Leads While Cardiovascular Surges

Orthopedics accounted for 30.22% of 2024 revenue and remains the anchor specialty. Predictable implant pricing, bundled payment familiarity, and robotic-assisted knee technology keep volumes high. The ambulatory surgical centers market maintains orthopedics as its most enormous pillar even as musculoskeletal reimbursement tightens.

Cardiovascular procedures, newly liberated by CMS site-of-service updates, will scale at a 9.65% CAGR. Early adopters are investing in hybrid cath labs and ICP-qualified nursing skill sets. Higher case complexity raises average revenue per procedure, positioning cardiology as a key earnings accelerator through 2030.

Geography Analysis

North America captured 36.44% of 2024 revenue, cementing its leadership position. Continued Certificate-of-Need rollbacks and consistent CMS payment updates encourage regional expansion. Robotic-enabled spine programs, underpinned by a USD 1 million donation to Halifax’s QEII Health Sciences Centre in January 2024, showcase the region’s tilt toward technology-rich high-acuity cases. These investments should lift regional case acuity and support modest pricing power despite payer scrutiny.

Europe presents a more heterogeneous adoption pattern. The United Kingdom, Germany, and France lead development, each leveraging public-private partnership frameworks that balance access mandates with private-sector efficiency. Stringent postoperative quality metrics and integrated care pathways support steady conversion of day-case potential into ambulatory volumes.

Asia delivers the fastest expansion, logging a projected 10.37% CAGR through 2030. Rising middle-class demand, private health-insurance growth, and public incentives for infrastructure build-outs spur construction across China and India. Multinational operators are trial-launching joint-venture ASCs within tertiary hospitals to mitigate regulatory risk while capturing self-pay demand. As procedure migration takes hold, the Asian contribution to global ambulatory surgical centers market share is set to rise materially.

Growth Rate By Region
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.
Get Analysis on Important Geographic Markets
Download PDF

Competitive Landscape

The sector remains moderately concentrated. The top five multi-facility groups hold a higher revenue share together, leaving ample room for independents. Tenet’s USPI division aims for up to 600 centers by 2025, leveraging system alliances to secure physician alignment.

Traditionally, hospital-centric device firms are pivoting to support ASC growth. In June 2024, Zimmer Biomet launched tailored joint-replacement education modules with Becker’s ASC, positioning implants alongside workflow consulting. Medtech vendors that offer inventory financing and implant-as-a-service models gain preferred-vendor status among cost-aware administrators.

Technology-enabled disruptors are emerging. Cloud-based revenue-cycle platforms and AI-driven scheduling SaaS vendors are lowering administrative burdens for single-site physicians. Early adopters report denial rates under 2% and staff productivity gains above 20%. These efficiencies help smaller operators remain independent in consolidating the ambulatory surgical center market.

Ambulatory Surgery Center Industry Leaders

  1. AMSURG

  2. Tenet Healthcare

  3. HCA Healthcare

  4. Surgical Care Affiliates

  5. Cerner Corporation

  6. *Disclaimer: Major Players sorted in no particular order
Ambulatory Surgery Center Market
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.
Need More Details on Market Players and Competitors?
Download PDF

Recent Industry Developments

  • January 2025: CMS announced that 53.4% of Traditional Medicare beneficiaries are now in accountable care relationships, with a goal of 100% by 2030, signaling continued emphasis on value-based care models that favor cost-effective ASC settings.
  • December 2024: CMS refined its nomination process for adding new procedures to the ASC list, signaling openness to stakeholder proposals.
  • November 2024: Georgia implemented HB 1339, revising the Certificate of Need process and introducing new exemptions for ASCs effective July 1, 2024, creating immediate market entry opportunities in previously restricted areas.
  • August 2024: CMS approved separate payments enabling small hospitals to stock essential medicines, indirectly stabilizing ASC supply chains.
  • August 2024: CMS announced the implementation of revised Medicare IPPS wage index values for FY 2025, impacting payment rates for hospital-owned ASCs and potentially altering competitive dynamics between hospital-owned and independent facilities.

Table of Contents for Ambulatory Surgery Center Industry Report

1. Introduction

  • 1.1 Study Assumptions & Market Definition
  • 1.2 Scope of the Study

2. Research Methodology

3. Executive Summary

4. Market Landscape

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Expansion of CMS-approved ASC Procedure List Accelerating High-Acuity Shift
    • 4.2.2 Certificate-of-Need (CON) Deregulation Enabling Rapid ASC Build-Outs
    • 4.2.3 High-Deductible Health Plans & Price-Transparency Rules Steering Patients Toward Low-Cost ASCs
    • 4.2.4 AI-driven Workflow/Navigation Solutions Raising Throughput in Ophthalmology and Ortho ASCs
    • 4.2.5 Rising Demand for Outpatient Surgeries
    • 4.2.6 Patient Convenience and Expansion in Emerging Markets
  • 4.3 Market Restraints
    • 4.3.1 Peri-operative Nurse and Anesthetist Shortages Limiting OR Utilisation Rates
    • 4.3.2 Reimbursement Gaps vs HOPD Eroding Margins in Cardiac & Spine Cases
    • 4.3.3 High Initial Setup Costs
    • 4.3.4 Shortage of Skilled Healthcare Professionals
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. Market Size & Growth Forecasts (Value in USD)

  • 5.1 By Center Type
    • 5.1.1 Single-Specialty Centers
    • 5.1.1.1 Gastroenterology Centers
    • 5.1.1.2 Ophthalmology Centers
    • 5.1.1.3 Orthopedic Centers
    • 5.1.1.4 Pain Management Centers
    • 5.1.1.5 Cardiology Centers
    • 5.1.1.6 Cosmetic Surgery Centers
    • 5.1.1.7 Other Single-Specialty
    • 5.1.2 Multi-Specialty Centers
  • 5.2 By Modality
    • 5.2.1 Hospital-based ASCs
    • 5.2.2 Freestanding ASCs
  • 5.3 By Ownership
    • 5.3.1 Physician-Owned
    • 5.3.2 Hospital-Owned
    • 5.3.3 Corporate / Private-Equity-Owned
    • 5.3.4 Joint-Venture
  • 5.4 By Services
    • 5.4.1 Surgical Services
    • 5.4.2 Diagnostic and Imaging Services
  • 5.5 By Specialty
    • 5.5.1 Gastroenterology
    • 5.5.2 Ophthalmology
    • 5.5.3 Orthopedics
    • 5.5.4 Pain / Neurology
    • 5.5.5 Cardiovascular
    • 5.5.6 ENT
    • 5.5.7 Urology
    • 5.5.8 Gynecology
    • 5.5.9 Plastics and Reconstructive
  • 5.6 Geography
    • 5.6.1 North America
    • 5.6.1.1 United States
    • 5.6.1.2 Canada
    • 5.6.1.3 Mexico
    • 5.6.2 Europe
    • 5.6.2.1 Germany
    • 5.6.2.2 United Kingdom
    • 5.6.2.3 France
    • 5.6.2.4 Italy
    • 5.6.2.5 Spain
    • 5.6.2.6 Rest of Europe
    • 5.6.3 Asia-Pacific
    • 5.6.3.1 China
    • 5.6.3.2 Japan
    • 5.6.3.3 India
    • 5.6.3.4 South Korea
    • 5.6.3.5 Australia
    • 5.6.3.6 Rest of Asia-Pacific
    • 5.6.4 Middle East and Africa
    • 5.6.4.1 GCC
    • 5.6.4.2 South Africa
    • 5.6.4.3 Rest of Middle East and Africa
    • 5.6.5 South America
    • 5.6.5.1 Brazil
    • 5.6.5.2 Argentina
    • 5.6.5.3 Rest of South America

6. Competitive Landscape

  • 6.1 Market Concentration
  • 6.2 Market Share Analysis
  • 6.3 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products & Services, and Recent Developments)
    • 6.3.1 AMSURG
    • 6.3.2 United Surgical Partners International
    • 6.3.3 HCA Healthcare
    • 6.3.4 Surgery Partners
    • 6.3.5 Surgical Care Affiliates (Optum)
    • 6.3.6 Envision Healthcare
    • 6.3.7 SurgCenter Development
    • 6.3.8 Regent Surgical Health
    • 6.3.9 PE GI Solutions
    • 6.3.10 NueHealth / ValueHealth
    • 6.3.11 NorthStar Healthcare
    • 6.3.12 TriasMD
    • 6.3.13 Vision Integrated Partners
    • 6.3.14 Nobilis Health
    • 6.3.15 Covenant Physician Partners
    • 6.3.16 Mednax Services
    • 6.3.17 TeamHealth
    • 6.3.18 SCA Health International
    • 6.3.19 St. George Surgical Center
    • 6.3.20 Muve Health (ValueHealth)

7. Market Opportunities & Future Outlook

  • 7.1 White-space & Unmet-need Assessment
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Research Methodology Framework and Report Scope

Market Definitions and Key Coverage

According to Mordor Intelligence, our study defines the ambulatory surgery center (ASC) market as the total annual revenue generated by stand-alone, non-hospital facilities that deliver same-day surgical, diagnostic, or preventive procedures. Single-specialty and multi-specialty centers operated by physicians, hospitals, or private investors in every region are counted.

Scope Exclusion: hospital outpatient departments, office-based procedure suites, and pure ASC IT service revenues.

Segmentation Overview

  • By Center Type
    • Single-Specialty Centers
      • Gastroenterology Centers
      • Ophthalmology Centers
      • Orthopedic Centers
      • Pain Management Centers
      • Cardiology Centers
      • Cosmetic Surgery Centers
      • Other Single-Specialty
    • Multi-Specialty Centers
  • By Modality
    • Hospital-based ASCs
    • Freestanding ASCs
  • By Ownership
    • Physician-Owned
    • Hospital-Owned
    • Corporate / Private-Equity-Owned
    • Joint-Venture
  • By Services
    • Surgical Services
    • Diagnostic and Imaging Services
  • By Specialty
    • Gastroenterology
    • Ophthalmology
    • Orthopedics
    • Pain / Neurology
    • Cardiovascular
    • ENT
    • Urology
    • Gynecology
    • Plastics and Reconstructive
  • Geography
    • North America
      • United States
      • Canada
      • Mexico
    • Europe
      • Germany
      • United Kingdom
      • France
      • Italy
      • Spain
      • Rest of Europe
    • Asia-Pacific
      • China
      • Japan
      • India
      • South Korea
      • Australia
      • Rest of Asia-Pacific
    • Middle East and Africa
      • GCC
      • South Africa
      • Rest of Middle East and Africa
    • South America
      • Brazil
      • Argentina
      • Rest of South America

Detailed Research Methodology and Data Validation

Primary Research

We interview ASC administrators, reimbursement managers, and device distributors across North America, Europe, Asia-Pacific, and the Gulf. Their insights on case-mix shifts, pricing pressure, and expansion pipelines let us stress-test secondary findings and close data gaps.

Desk Research

Mordor Intelligence analysts first map the global stock of licensed ASCs through open sources such as CMS Provider of Services files, Eurostat, Japan MHLW facility lists, and the Ambulatory Surgery Center Association. Procedure volumes, tariff schedules, and replacement cycles are then drawn from WHO expenditure tables, national fee manuals, peer-reviewed journals, and large 10-Ks. D&B Hoovers and Dow Jones Factiva supply missing financial ranges.

The sources listed are illustrative, not exhaustive.

Market-Sizing & Forecasting

We begin top-down: active center count multiplied by average revenue per center, reconstructed from capacity, payer mix, and typical reimbursement. Results are cross-checked with sampled bottom-up roll-ups of chain disclosures and channel ASP multiplied by volume probes. Key inputs include procedure volumes, reimbursement updates, regulatory additions to the ASC-approved list, inflation, and capital renewal cycles. A multivariate regression on these variables, supported by scenario bands for policy shocks, yields the 2025-2030 curve. Gaps are bridged with medians from comparable centers. This is where Mordor Intelligence differentiates by blending quantified drivers with on-ground sentiment.

Data Validation & Update Cycle

We run variance screens, peer review, and management sign-off. Models refresh every twelve months, reopening sooner when policy or M&A events move baselines, so clients always receive the newest view.

Why Mordor's Ambulatory Surgery Center Baseline Commands Confidence

Published figures diverge because firms choose different facility mixes, revenue lines, and refresh timings.

By anchoring on audited center counts, real-world economics, and a balanced top-down and bottom-up blend, we provide a traceable midpoint for decision making.

Benchmark comparison

Market Size Anonymized source Primary gap driver
USD 83.88 B (2025) Mordor Intelligence -
USD 88.93 B (2025) Global Consultancy A Adds software and hardware sales to service revenue
USD 142.86 B (2024) Industry Association B Bundles hospital outpatient departments and applies broad healthcare spend ratios

The comparison shows how wider or narrower scopes inflate totals, whereas Mordor Intelligence's disciplined variable set and annual refresh keep our baseline reliable, transparent, and easy to audit.

Need A Different Region or Segment?
Customize Now

Key Questions Answered in the Report

What is driving the rapid growth of cardiovascular procedures in the ambulatory surgical centers market?

Higher-acuity cardiac interventions were added to the CMS ASC Covered Procedures List for 2025, enabling centers with hybrid cath labs to capture new volumes forecast to rise at a 10.2% CAGR through 2030.

How do freestanding centers compare financially with hospital-based ASCs?

Freestanding facilities controlled 66.74% of 2024 revenue and often benefit from lower overheads, whereas hospital-based sites are expected to log an 9.2% CAGR as systems repurpose unused outpatient space.

Why are multi-specialty ASCs growing faster than single-specialty sites?

Diversified case mixes cushion reimbursement risk and lift scheduling density, supporting a 8.52% CAGR for multi-specialty centers versus slower single-specialty growth.

What staffing challenges most impact ASC growth?

Shortages of peri-operative nurses and CRNAs suppress room utilisation and add wage pressure, with recruitment gaps estimated to trim overall CAGR by 1.4 percentage points in the short term.

Are diagnostic services becoming a meaningful revenue stream for ASCs?

Yes, diagnostic and imaging lines, currently 22.77% of revenue, are projected to grow at 8.74% annually, allowing centers to offer end-to-end care and improve scheduling efficiency.

Page last updated on:

Ambulatory Surgery Center Report Snapshots